Stay updated on Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to include new information about the study of Filgrastim and Peg-filgrastim, along with details about the collaborators involved, while significant content regarding the drug talazoparib has been removed.SummaryDifference48%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.